Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus
Condition(s):Systemic Lupus ErythematosusLast Updated:June 24, 2005Completed
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:June 24, 2005Completed
Condition(s):Addison’s DiseaseLast Updated:June 24, 2005Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:January 14, 2008Completed
Condition(s):Primary Ovarian InsufficiencyLast Updated:April 10, 2018Completed
Condition(s):Breast CancerLast Updated:July 24, 2012Terminated
Condition(s):AgingLast Updated:March 23, 2011Completed
Condition(s):Metabolic Side Effects of DrugsLast Updated:October 27, 2023Completed
Condition(s):Adrenal Incidentaloma; Subclinical HypercortisolismLast Updated:April 15, 2022Recruiting
Condition(s):Dietary SupplementsLast Updated:July 22, 2022Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:June 24, 2005Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.